Literature DB >> 26712218

p300 is not required for metabolic adaptation to endurance exercise training.

Samuel A LaBarge1, Christopher W Migdal1, Elisa H Buckner1, Hiroshi Okuno1, Ilya Gertsman1, Ben Stocks1, Bruce A Barshop1, Sarah R Nalbandian1, Andrew Philp1, Carrie E McCurdy1, Simon Schenk2.   

Abstract

The acetyltransferase, E1a-binding protein (p300), is proposed to regulate various aspects of skeletal muscle development, metabolism, and mitochondrial function,viaits interaction with numerous transcriptional regulators and other proteins. Remarkably, however, the contribution of p300 to skeletal muscle function and metabolism,in vivo, is poorly understood. To address this, we used Cre-LoxP methodology to generate mice with skeletal muscle-specific knockout of E1a-binding protein (mKO). mKO mice were indistinguishable from their wild-type/floxed littermates, with no differences in lean mass, skeletal muscle structure, fiber type, respirometry flux, or metabolites of fatty acid and amino acid metabolism.Ex vivomuscle function in extensor digitorum longus and soleus muscles, including peak stress and time to fatigue, as well asin vivorunning capacity were also comparable. Moreover, expected adaptations to a 20 d voluntary wheel running regime were not compromised in mKO mice. Taken together, these findings demonstrate that p300 is not required for the normal development or functioning of adult skeletal muscle, nor is it required for endurance exercise-mediated mitochondrial adaptations.-LaBarge, S. A., Migdal, C. W., Buckner, E. H., Okuno, H., Gertsman, I., Stocks, B., Barshop, B. A., Nalbandian, S. R., Philp, A., McCurdy, C. E., Schenk, S. p300 is not required for metabolic adaptation to endurance exercise training. © FASEB.

Entities:  

Keywords:  acetyltransferase; knockout; metabolomics; mitochondria; physiology

Mesh:

Substances:

Year:  2015        PMID: 26712218      PMCID: PMC4799503          DOI: 10.1096/fj.15-281741

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  62 in total

Review 1.  CBP/p300 in cell growth, transformation, and development.

Authors:  R H Goodman; S Smolik
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

2.  Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation.

Authors:  R Eckner; T P Yao; E Oldread; D M Livingston
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

Review 3.  50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond.

Authors:  Eric Verdin; Melanie Ott
Journal:  Nat Rev Mol Cell Biol       Date:  2014-12-30       Impact factor: 94.444

4.  Activation of PPARgamma coactivator-1 through transcription factor docking.

Authors:  P Puigserver; G Adelmant; Z Wu; M Fan; J Xu; B O'Malley; B M Spiegelman
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

5.  Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux.

Authors:  Qijun Wang; Yakun Zhang; Chen Yang; Hui Xiong; Yan Lin; Jun Yao; Hong Li; Lu Xie; Wei Zhao; Yufeng Yao; Zhi-Bin Ning; Rong Zeng; Yue Xiong; Kun-Liang Guan; Shimin Zhao; Guo-Ping Zhao
Journal:  Science       Date:  2010-02-19       Impact factor: 47.728

6.  Deacetylation of phosphoglycerate mutase in its distinct central region by SIRT2 down-regulates its enzymatic activity.

Authors:  Takeshi Tsusaka; Tingting Guo; Teiti Yagura; Toshiaki Inoue; Masayuki Yokode; Nobuya Inagaki; Hiroshi Kondoh
Journal:  Genes Cells       Date:  2014-09-08       Impact factor: 1.891

7.  Differential roles of p300 and PCAF acetyltransferases in muscle differentiation.

Authors:  P L Puri; V Sartorelli; X J Yang; Y Hamamori; V V Ogryzko; B H Howard; L Kedes; J Y Wang; A Graessmann; Y Nakatani; M Levrero
Journal:  Mol Cell       Date:  1997-12       Impact factor: 17.970

8.  MetaboAnalyst 3.0--making metabolomics more meaningful.

Authors:  Jianguo Xia; Igor V Sinelnikov; Beomsoo Han; David S Wishart
Journal:  Nucleic Acids Res       Date:  2015-04-20       Impact factor: 16.971

9.  Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program.

Authors:  V Sartorelli; P L Puri; Y Hamamori; V Ogryzko; G Chung; Y Nakatani; J Y Wang; L Kedes
Journal:  Mol Cell       Date:  1999-11       Impact factor: 17.970

10.  S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase.

Authors:  Victor Aguilar; Samira Alliouachene; Athanassia Sotiropoulos; Andrew Sobering; Yoni Athea; Fatima Djouadi; Sylvain Miraux; Eric Thiaudière; Marc Foretz; Benoit Viollet; Philippe Diolez; Jean Bastin; Paule Benit; Pierre Rustin; David Carling; Marco Sandri; Renée Ventura-Clapier; Mario Pende
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

View more
  11 in total

Review 1.  Exercise adaptations: molecular mechanisms and potential targets for therapeutic benefit.

Authors:  Sean L McGee; Mark Hargreaves
Journal:  Nat Rev Endocrinol       Date:  2020-07-06       Impact factor: 43.330

2.  Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.

Authors:  Vitor F Martins; Jessica R Dent; Kristoffer Svensson; Shahriar Tahvilian; Maedha Begur; Shivani Lakkaraju; Elisa H Buckner; Samuel A LaBarge; Byron Hetrick; Carrie E McCurdy; Simon Schenk
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-19       Impact factor: 4.310

3.  Dynamic Glucose Disposal is Driven by Reduced Endogenous Glucose Production in Response to Voluntary Wheel Running: A Stable Isotope Approach.

Authors:  Timothy D Allerton; Greg Kowalski; Hardy Hang; Jacqueline Stephens
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-04-28       Impact factor: 4.310

4.  Skeletal muscle mitochondrial function and exercise capacity are not impaired in mice with knockout of STAT3.

Authors:  Jessica R Dent; Byron Hetrick; Shahriar Tahvilian; Abha Sathe; Keenan Greyslak; Samuel A LaBarge; Kristoffer Svensson; Carrie E McCurdy; Simon Schenk
Journal:  J Appl Physiol (1985)       Date:  2019-09-12

5.  Temporal overexpression of SIRT1 in skeletal muscle of adult mice does not improve insulin sensitivity or markers of mitochondrial biogenesis.

Authors:  K Svensson; S A LaBarge; V F Martins; S Schenk
Journal:  Acta Physiol (Oxf)       Date:  2017-06-13       Impact factor: 6.311

6.  p300 Mediates Muscle Wasting in Lewis Lung Carcinoma.

Authors:  Thomas K Sin; James Z Zhu; Guohua Zhang; Yi-Ping Li
Journal:  Cancer Res       Date:  2019-01-31       Impact factor: 12.701

7.  Combined overexpression of SIRT1 and knockout of GCN5 in adult skeletal muscle does not affect glucose homeostasis or exercise performance in mice.

Authors:  Kristoffer Svensson; Shahriar Tahvilian; Vitor F Martins; Jessica R Dent; Adrianna Lemanek; Neeka Barooni; Keenan Greyslak; Carrie E McCurdy; Simon Schenk
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-12-03       Impact factor: 4.310

8.  Muscle-specific knockout of general control of amino acid synthesis 5 (GCN5) does not enhance basal or endurance exercise-induced mitochondrial adaptation.

Authors:  Jessica R Dent; Vitor F Martins; Kristoffer Svensson; Samuel A LaBarge; Noah C Schlenk; Mary C Esparza; Elisa H Buckner; Gretchen A Meyer; D Lee Hamilton; Simon Schenk; Andrew Philp
Journal:  Mol Metab       Date:  2017-10-16       Impact factor: 7.422

9.  Calorie Restriction-Induced Increase in Skeletal Muscle Insulin Sensitivity Is Not Prevented by Overexpression of the p55α Subunit of Phosphoinositide 3-Kinase.

Authors:  Vitor F Martins; Shahriar Tahvilian; Ji H Kang; Kristoffer Svensson; Byron Hetrick; Wallace S Chick; Simon Schenk; Carrie E McCurdy
Journal:  Front Physiol       Date:  2018-06-27       Impact factor: 4.566

10.  p300 and cAMP response element-binding protein-binding protein in skeletal muscle homeostasis, contractile function, and survival.

Authors:  Kristoffer Svensson; Samuel A LaBarge; Abha Sathe; Vitor F Martins; Shahriar Tahvilian; Jennifer M Cunliffe; Roman Sasik; Sushil K Mahata; Gretchen A Meyer; Andrew Philp; Larry L David; Samuel R Ward; Carrie E McCurdy; Joseph E Aslan; Simon Schenk
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-01-03       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.